California State Teachers Retirement System (CalSTRS)’s Candel Therapeutics CADL Stock Holding History
Bought
Maintained
Sold
Other funds holding CADL
RI
ACA
SVCM
PCM
VCM
VPC
California State Teachers Retirement System (CalSTRS)'s CADL Position: Q1 2026 in Review
California State Teachers Retirement System (CalSTRS) reduced its Candel Therapeutics (CADL) stake by 12% in Q1 2026, selling an estimated $1.78K and leaving 2,372 shares worth $11.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2628.
California State Teachers Retirement System (CalSTRS) first reported a position in CADL in Q2 2024 and has held it in 8 quarters since. The position peaked at $15.2K in Q4 2025. 114 funds tracked by Wall St. Rank hold CADL as of Q1 2026.
- California State Teachers Retirement System (CalSTRS) held 2,372 shares of Candel Therapeutics worth $11.6K as of Q1 2026.
- California State Teachers Retirement System (CalSTRS) sold 327 Candel Therapeutics shares in Q1 2026, an estimated $1.78K.
- Candel Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #2628 holding.
- California State Teachers Retirement System (CalSTRS) first reported a position in Candel Therapeutics in Q2 2024 and has held it in 8 quarters since.
- California State Teachers Retirement System (CalSTRS)'s Candel Therapeutics position peaked at $15.2K in Q4 2025.
- 114 funds tracked by Wall St. Rank held Candel Therapeutics as of Q1 2026.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.